Name | L-Lysinamide, N-acetyl-L-norleucyl-L-α-aspartyl-β-alanyl-3-(2-naphthalenyl)-D-alanyl-L-arginyl-L-tryptophyl-, (2→7)-lactam |
---|---|
Synonyms | MMPIP hydrochloride |
Description | PG106 is a potent and selective human melanocortin 3 (hMC3) receptor antagonist (IC50=210 nM) and has noactivity at hMC4 receptors (EC50=9900 nM) and hMC5 receptor[1]. |
---|---|
Related Catalog | |
Target |
IC50: 210 nM (hMC3 receptor) EC50: 9900 nM (hMC4 receptor)[1] |
References |
Density | 1.40±0.1 g/cm3 (20 °C, 760 mmHg) |
---|---|
Molecular Formula | C51H69N13O9 |
Molecular Weight | 1008.18000 |
Exact Mass | 1007.53000 |
PSA | 353.58000 |
LogP | 4.81610 |